secwatch / observer
8-K filed December 20, 2024, 6:59 PM ET ticker MIRA CIK 0001904286
other material confidence high sentiment negative materiality 0.70

MIRA PHARMACEUTICALS, INC. (MIRA): auditor change — MIRA Pharmaceuticals replaces auditor Cherry Bekaert with Salberg; material weaknesses cited

MIRA PHARMACEUTICALS, INC.

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

MIRA PHARMACEUTICALS, INC. engaged Salberg & Company P.A. as its auditor.

Action
engagement
Auditor
Salberg & Company P.A.
Exact text from the filing
On December 18 th , 2024, the Company engaged Salberg & Company P.A. (“Salberg”) as its new independent registered public accountant for the fiscal year ending December 31, 2024.
View on SEC.gov
Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Cherry Bekaert LLP resigned as auditor of MIRA PHARMACEUTICALS, INC..

Action
resignation
Auditor
Cherry Bekaert LLP
Exact text from the filing
By letter dated December 16, 2024, Cherry Bekaert LLP (“Cherry Bekaert”) notified the Audit Committee of the Board of Directors (the “Audit Committee”) of MIRA Pharmaceuticals, Inc’s (the “Company”) of its resignation as the Company’s independent registered public accounting firm.
View on SEC.gov

46 auditor changes filed in the last 30 days. Browse all auditor changes →

MIRA PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR
accession 0001493152-24-051091
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.